<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">27896515</PMID>
<DateCompleted>
<Year>2018</Year>
<Month>02</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>02</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1534-4681</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>24</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2017</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Annals of surgical oncology</Title>
<ISOAbbreviation>Ann. Surg. Oncol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 Study.</ArticleTitle>
<Pagination>
<MedlinePgn>1314-1321</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1245/s10434-016-5687-0</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Analyzing the large patient cohort of the multicenter AGO-CaRE-1 study, we compared isolated sentinel lymph node dissection (SLND) with radical lymph node dissection (LND) of the groin in relation to recurrence rates and survival.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The AGO-CaRE-1 study retrospectively collected data on treatment patterns and follow-up of vulvar cancer patients [International Federation of Gynecology and Obstetrics (FIGO) stage ≥1B] treated at 29 gynecologic cancer centers between 1998 and 2008. This subgroup analysis evaluated the influence of SLND alone on progression-free survival (PFS) and overall survival (OS).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In 487 (63.1%) of 772 included patients with tumors smaller than 4 cm, an LND was performed and no metastatic lymph nodes were detected (LN0). Another 69/772 (8.9%) women underwent SLND alone, showing a negative SLN (SLN0). Tumors in the LN0 group were larger and showed a deeper invasion (LN0 vs. SLN0 tumor diameter: 20.0 vs. 13.0 mm, p &lt; 0.001; depth of invasion: 4.0 vs. 3.0 mm, p = 0.002). After a median follow-up of 33 months (0-156), no significant differences in relation to isolated groin recurrence rates (SLN0 3.0% vs. LN0 3.4%, p = 0.845) were detected. Similarly, univariate 3-year PFS analysis showed no significant differences between both groups (SLN0 82.7% vs. LN0 77.6%, p = 0.230). A multivariate Cox regression analysis, including tumor diameter, depth of invasion, age, grading, and lymphovascular space invasion was performed: PFS [hazard ratio (HR) 0.970, 95% confidence interval (CI) 0.517-1.821] and OS (HR 0.695, 95% CI 0.261-1.849) did not differ significantly between both cohorts.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This subgroup analysis of the large AGO-CaRE-1 study showed similar results for groin LND and SLND alone with regard to recurrence rates and survival in node-negative patients with tumors &lt;4 cm.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Klapdor</LastName>
<ForeName>Rüdiger</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany. klapdor.ruediger@mh-hannover.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hillemanns</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wölber</LastName>
<ForeName>Linn</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jückstock</LastName>
<ForeName>Julia</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology and Obstetrics, University of Munich, Munich, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hilpert</LastName>
<ForeName>Felix</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Jerusalem Hospital, Hamburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Gregorio</LastName>
<ForeName>Nikolaus</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology, University of Ulm, Ulm, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Iborra</LastName>
<ForeName>Severine</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, University Medical Center - RWTH, Aachen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sehouli</LastName>
<ForeName>Jalid</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology, Charité - University Medicine Berlin, Berlin, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Habermann</LastName>
<ForeName>Anika</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology, University of Magdeburg, Magdeburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fürst</LastName>
<ForeName>Sophie Teresa</ForeName>
<Initials>ST</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology, University of Munich-Grosshadern, Munich, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Strauß</LastName>
<ForeName>Hans Georg</ForeName>
<Initials>HG</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology, University of Halle, Halle, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baumann</LastName>
<ForeName>Klaus</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology, Klinikum Ludwigshafen, Ludwigshafen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thiel</LastName>
<ForeName>Falk</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology, Alb Fils Kliniken, Klinik am Eichert, Goeppingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mustea</LastName>
<ForeName>Alexander</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology, University Medicine of Greifswald, Greifswald, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Meier</LastName>
<ForeName>Werner</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology, Evangelisches Krankenhaus Duesseldorf, Duesseldorf, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Harter</LastName>
<ForeName>Philipp</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology, Kliniken Essen Mitte, Essen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wimberger</LastName>
<ForeName>Pauline</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology and Obstetrics, Carl-Gustav-Carus University Dresden, Dresden, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hanker</LastName>
<ForeName>Lars</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology, UKSH Campus Lübeck, Lübeck, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schmalfeldt</LastName>
<ForeName>Barbara</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology and Obstetrics, University of Munich, Munich, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Canzler</LastName>
<ForeName>Ulrich</ForeName>
<Initials>U</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology and Obstetrics, Carl-Gustav-Carus University Dresden, Dresden, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fehm</LastName>
<ForeName>Tanja</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology, Düsseldorf University Hospital, Düsseldorf, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Gynecology and Obstetrics, University of Tübingen, Tübingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Luyten</LastName>
<ForeName>Alexander</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology, Wolfsburg Hospital, Wolfsburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hellriegel</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology, Georg-August-University Goettingen, Goettingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kosse</LastName>
<ForeName>Jens</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology, SANA Hospital Offenbach, Offenbach, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Heiss</LastName>
<ForeName>Christoph</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology, Alb Fils Kliniken, Klinik am Eichert, Goeppingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hantschmann</LastName>
<ForeName>Peer</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology, Hospital Altoettingen, Altoettignen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mallmann</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology, University Hospital Cologne, Cologne, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tanner</LastName>
<ForeName>Berno</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Oberhavel Hospital, Oranienburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pfisterer</LastName>
<ForeName>Jacobus</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Gynecologic Oncology Center, Kiel, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Richter</LastName>
<ForeName>Barbara</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Elbland Hospital Meißen-Radebeul, Radebeul, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jäger</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute for Biometrics, Hannover Medical School, Hannover, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mahner</LastName>
<ForeName>Sven</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynecology and Obstetrics, University of Munich, Munich, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>11</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Ann Surg Oncol</MedlineTA>
<NlmUniqueID>9420840</NlmUniqueID>
<ISSNLinking>1068-9265</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000367">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018572">Disease-Free Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007264">Inguinal Canal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008197">Lymph Node Excision</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008207">Lymphatic Metastasis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D060787">Neoplasm Grading</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009361">Neoplasm Invasiveness</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D009364">Neoplasm Recurrence, Local</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009367">Neoplasm Staging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000071036">Sentinel Lymph Node</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015996">Survival Rate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D047368">Tumor Burden</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014846">Vulvar Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>09</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>11</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2018</Year>
<Month>2</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>11</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">27896515</ArticleId>
<ArticleId IdType="doi">10.1245/s10434-016-5687-0</ArticleId>
<ArticleId IdType="pii">10.1245/s10434-016-5687-0</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>